CIK 0001835579 · <br>Emerging growth company
ImageneBio, Inc.
Sign in to watch- Ticker
- IMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811697316
- Phone
- 857-343-8292
- Business address
- 12526 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Former names
- Ikena Oncology, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-25 | Lu Yufang Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +6,102 | 6,102 | ||
| 2025-07-25 | Bonita David P Director | Option exercise | +379 | 379 | ||
| 2025-07-25 | Bonita David P Director | Purchase | +83,611 | $29.90 | $2.5M | 287,885 |
| 2025-07-25 | Bonita David P Director | Option exercise · Stock Option (right to buy) | −17,520 | 0 | ||
| 2025-07-25 | Stampacchia Otello Director | Option exercise | +379 | 379 | ||
| 2025-07-25 | Stampacchia Otello Director | Purchase | +267,556 | $29.90 | $8.0M | 454,982 |
| 2025-07-25 | Stampacchia Otello Director | Option exercise · Stock Option (right to buy) | −17,520 | 0 | ||
| 2025-07-25 | ORBIMED ADVISORS LLC Director | Grant or award | +83,611 | $2.49 | $208K | 287,885 |
| 2025-07-25 | Butler Erin Principal Accounting Officer | Grant or award | +3,051 | 3,051 | ||
| 2025-07-25 | Butler Erin Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +3,813 | 3,813 | ||
| 2025-07-25 | Marango Jotin Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −181,000 | 0 | ||
| 2025-07-25 | Marango Jotin Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −105,000 | 0 | ||
| 2025-07-25 | Marango Jotin Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −397,199 | 0 | ||
| 2024-06-07 | Wooster Richard Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2024-06-07 | Dukes Iain D. Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2024-06-07 | Koehler Maria Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2024-06-07 | Stampacchia Otello Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2024-06-07 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2024-06-07 | Bonita David P Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 | ||
| 2024-06-07 | Hughes Owen Director | Grant or award · Stock Option (Right to Buy) | +17,520 | 17,520 |
Page 3 of 12 · 222 trades